• 1
    ILSI. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. Inhal Toxicol 2000; 12: 117.
  • 2
    Abbey DE, Nishino N, McDonnel WF, Burchette RJ, Knutsen SF, Beeson WL, Yang JX. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 1999; 159: 37382.
  • 3
    Pope CAI, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002; 287: 113241.
  • 4
    Mossman BT, Bignon J, Corn M, Seaton A, Gee JB. Asbestos: scientific developments and implications for public policy. Science 1990; 247: 294301.
  • 5
    Donaldson K, Borm PJA. The quartz hazard: a variable entity. Ann Occup Hyg 1998; 42: 52130.
  • 6
    Nikula KJ. Rat lung tumors induced by exposure to selected poorly soluble particles. Inhal Toxicol 2000; 12: 97119.
  • 7
    Nikula KJ, Snipes MB, Barr EB, Griffith WC, Henderson RF, Mauderly JL. Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust. Fundam Appl Toxicol 1995; 37: 3753.
  • 8
    Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch W, Levsen K. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black and titanium dioxide. Inhal Toxicol 1995; 7: 53356.
  • 9
    Oberdörster G. Significance of particle parameters in the evaluation of exposure–response relationships of inhaled particles. Inhal Toxicol 1996; 8(Suppl 1): 7389.
  • 10
    Peters A, Doring, Wichmann HE, Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997; 349: 15827.
  • 11
    Pekkanen J, Peters A, Hoek G, Tiittanen P, Brunekreef B, de Hartog J, Heinrich J, Ibald-Mulli A, Kreyling WG, Lanki T, Timonen KL, Vanninen E. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study. Circulation 2002; 106: 9338.
  • 12
    Nordenhall C, Pourazar J, Ledin MC, Levin JO, Sandström T, Adelroth E. Diesel exhaust enhances airway responsiveness in asthmatic subjects. Eur Respir J 2001; 17: 90915.
  • 13
    Oberdörster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001; 74: 18.
  • 14
    Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Tran L, Stone V. The pulmonary toxicology of ultrafine particles. J Aerosol Med 2002; 15: 21320.
  • 15
    Malakoff D. Nanotechnology research. Congress wants studies of nanotech's “dark side”. Science 2003; 301: 27.
  • 16
    Borm PJA, Kreyling W. Toxicological hazards of inhaled nanoparticles—potential implications for drug delivery. J Nanosci Nanotechnol, in press.
  • 17
    Knaapen A, Borm PJA, Albrecht C, Schins RPF. Inhaled particles and lung cancer. Part A: mechanisms. Int J Cancer 2004; 109:, in press.
  • 18
    Sharma OP, Lamb C. Cancer in interstitial pulmonary fibrosis and sarcoidosis. Curr Opin Pulm Med 2003; 9: 398401.
  • 19
    Carta P, Aru G, Manca P. Mortality from lung cancer among silicotic patients in Sardinia: an update study with 10 more years of follow up. Occup Environ Med 2001; 58: 78693.
  • 20
    Dutch Expert Committee on Occupational Standards (DECOS). Committee on the Evaluation of the Carcinogenicity of Chemical Substances. Quartz. Evaluation of the carcinogenicity and genotoxicity. Publication 1998/02WGD. Rijswijk: Health Council of the Netherlands, 1998.
  • 21
    Vincent JH, Johnston AM, Jones AD, Bolton RE, Addison J. Kinetics of deposition and clearance of inhaled mineral dusts chronic exposure. Br J Ind Med 1985; 42: 70715.
  • 22
    Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Utell MJ, Framptom MW. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol 2003; 15: 53952.
  • 23
    Tran CL, Jones AD, Cullen RT, Donaldson K. Exploration of the mechanisms of retention and clearance of low-toxicity particles in the rat lung using a mathematical model. Inhal Toxicol 1999; 11: 1077108.
  • 24
    Little JB, Radford EP, McCombs HL, Hunt VR. Distribution of polonium-210 in pulmonary tissues of cigarette smokers. N Engl J Med 1965; 273: 134351.
  • 25
    Churg A, Vedal S. Carinal and tubular airway particle concentrations in the large airways of non-smokers in the general population: evidence for high concentration at airway carinas. Occup Environ Med 1996; 53: 5538.
  • 26
    Balashazy I, Hofmann W, Heistracher T. Local particle deposition patterns may play a key role in the development of lung cancer. J Appl Physiol 2003; 94: 171925.
  • 27
    Subramaniam RP, Asgharian B, Freijer JI, Miller FJ, Anjilbel S. Analysis of lobar differences in particle deposition in the human lung. Inhal Toxicol 2003; 15: 121.
  • 28
    Brody AR, Hill LH, Adkins B, O'Connor RW. Chrysotile asbestos inhalation in rats: deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 1981; 123: 6709.
  • 29
    Kreyling WG, Scheuch G. Clearance of particles deposited in the lungs. In: GehrP, HeyderJ, eds. Particle lung interactions. New York: Marcel Dekker, 2000. 32376.
  • 30
    Oberdorster G. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol 2002; 14: 2956.
  • 31
    Morrow PE. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 1992; 113: 112.
  • 32
    Oberdorster G. Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol 1995; 27: 12335.
  • 33
    Renwick LC, Donaldson K, Clouter A. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 2002; 172: 11927.
  • 34
    IARC. Monographs on the evaluation of carcinogenic risks to humans: man made mineral fibres. vol. 81, Lyon: IARC, 2001.
  • 35
    Moghimi SM, Hunter AC. Capture of stealth nanoparticles by the body defences. Crit Rev Ther Drug Carrier Syst 2001; 18: 52750.
  • 36
    Nemmar A, Hoet P, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 2002; 105: 4114.
  • 37
    Nikula KJ, Avila KJ, Griffith WC, Mauderly JL. Sites of particle deposition and lung tissue responses to chronically inhaled diesel exhaust and coal dust in rats and cynomolgus monkeys. Environ Health Persp 1997; 105(Suppl 5): 12314.
  • 38
    Oberdörster G, Utell MJ. Ultrafine particles in the urban air: to the respiratory tract—and beyond? Environ Health Perspect 2002; 110: A4401.
  • 39
    De Lorenzo A, Darin J. In: WolstenholmeGEW, KnightJ, eds. Taste and smell in vertebrates. London: Churchill, 1970. 15176.
  • 40
    Pott F, Roller M, Althoff G-H, Rittinghausen S, Ernst H, Mohr U. Carcinogenicity of poorly soluble particles in rats—in man too? In: Proceedings of the 7th International Inhalation Symposium. Washington DC: ILSI Press, 2000. 23552.
  • 41
    Driscoll KE. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. Inhal Toxicol 1996; 8: 13953.
  • 42
    Zhang Q, Kusaka Y, Sato K, Nakakuki K, Kohyama N, Donaldson K. Differences in the extent of inflammation by intratracheal exposure to three ultrafine metals: role of free radicals. J Toxicol Environ Health 1998; 53: 42338.
  • 43
    Dick CAJ, Brown DM, Donaldson K, Stone V. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal Toxicol 2003; 15: 3952.
  • 44
    Duffin R, Tran L, Clouter A, Brown D, MacNee W, Stone V, Donaldson K. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann Occup Hyg 2002; 46(Suppl 1): 2425.
  • 45
    Ferin J, Oberdorster G, Soderholm SC, Gelein R. The rate of dose-delivery affects pulmonary interstitialisation of particles in rats. Ann Occup Hyg 1994; 38(Suppl 1): 28993.
  • 46
    Churg A. Particle uptake in epithelial cells. In: GehrP, HeyderJ, eds. Particle lung interactions. vol. 143. Lung biology in health and disease. New York: Marcel Dekker, 2002. 40135.
  • 47
    Borm PJA, Höhr D, Steinfartz Y, Zeitträger I, Albrecht C. Chronic inflammation and tumor formation in rats after intratracheal instillation of high doses of coal dusts, titanium oxides and quartz. Inhal Toxicol 2000; 12(Suppl 3): 22531.
  • 48
    Höhr D, Steinfartz Y, Martra G, Fubini B, Borm PJA. The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO2 in the rat. Int J Hyg Environ Health 2002; 205: 23944.
  • 49
    Rehn B, Seiler F, Rehn S, Bruch J, Maier M. Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: untreated and surface treated. Toxicol Appl Pharmacol 2003; 189: 8495.
  • 50
    Pott F, Althoff G-H, Roller M, Höhr D, Friemann J. High acute toxicity of hydrophobic ultrafine titanium dioxide in an intratracheal study with several dusts in rats. In: DungworthDL, BrainJD, DriscollKE, GrafströmRC, HarrisCC, eds. Relationships between respiratory disease and exposure to air pollution. ICSI Press, Washington, DC. 1998. 2702.
  • 51
    Lee KP, Henry NW, Trochimowcz HJ, Reinhard CF. Pulmonary response to impaired lung clearance in rats following excessive TiO2 dust deposition. Environ Res 1985; 41: 14467.
  • 52
    Lee KP, Trochimowcz HJ, Reinhard CF. Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for 2 years. Toxicol Appl Pharmacol 1986; 79: 17992.
  • 53
    Hext PM. Current perspectives on particulate induced pulmonary tumors. Hum Exp Toxicol 1994; 13: 70015.
  • 54
    Friemann J, Albrecht C, Breuer P, Grover R, Weishaupt C. Time-course analysis of type II cells hyperplasia and alveolar bronchiolization in rats treated with different particulates. Inhal Toxicol 1999; 11: 83754.
  • 55
    Mohr U, Rittinghausen S, Takenaka S, Ernst H, Dungworth DLK, Pylev LN. Tumors of the lower respiratory tract and pleura in the rat. In: TurusovV, MohrU, eds. Pathology of tumors in laboratory animals. Tumors of the rat. vol. I, 2nd ed. Lyon: IARC, 1990. 27589.
  • 56
    Hahn FF, Boorman GA. Neoplasia and preneoplasia of the lung. In: BannaschP, GossnerW, eds. Pathology of neoplasia and preneoplasia in rodents. EULEP color atlas. vol. 2. Stuttgart: Schattauer, 1997. 2042.
  • 57
    Grigg J, Hewitt CRA, McGarr C, MacNee W, Donaldson K. Homotypic aggregation of rat alveolar macrophages stimulated by ultrafine carbon black is associated with upregulation if intercellular adhesion molecule-1. Ann Occup Hyg 2002; 43(Suppl 1): 22730.
  • 58
    Gilmour PS, Rahman I, Donaldson K, MacNee W. Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. Am J Physiol Lung Cell Mol Physiol 2003; 284: L53340.
  • 59
    Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003; 111: 45560.
  • 60
    Stone V, Tuinman M, Vamvakopoulos JE, Shaw J, Brown D, Petterson S, Faux SP, Borm P, MacNee W, Michaelangeli F, Donaldson K. Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur Respir J 2000; 15: 297303.
  • 61
    Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 2002; 121: 127889.
  • 62
    Attfield MA, Seixas NS. Prevalence of pneumoconiosis and its relationship to dust exposure in a cohort of US bituminous coal miners and ex-coal miners. Am J Ind Med 1995; 27: 13751.
  • 63
    Schins RPF, Borm PJA. Epidemiological evaluation of monocyte TNF release as an exposure and effect marker in pneumoconiosis—a five year follow-up study among coal workers. Occup Environ Med 1995; 52: 44150.
  • 64
    Morfeld P, Lampert K, Ziegler H, Stegmaier C, Dhlom G, Piekarski C. Overall mortality and cancer mortality of coal miners: attempts to adjust for healthy worker selection effects. Ann Occup Hyg 1996; 41(Suppl 1): 34651.
  • 65
    Checkoway H, Franzblau A. Is silicosis required for silica-associated lung cancer? Am J Ind Med 2000; 37: 2529.
  • 66
    Morfeld P, Lampert K, Emmerich M, Stegmaier C, Piekarski C. Coal mine dust exposure, quartz dust exposure, pneumoconiosis development and lung cancer risk: results from a mortality follow-up study in German coal mining. Med Lav 2002; 93: S31.
  • 67
    Porter DW, Ramsey D, Hubbs A, Battelli L, Ma J, Barger M, Landstittle D, Robinson VA, McLaurin J, Khan A, Jones W, Teass A, Castranova V. Time course of pulmonary response to inhalation of crystalline silica: histological results and biochemical indices of damage, lipidosis and fibrosis. J Environ Toxicol Pathol 2000; 20(Suppl 1): 114.
  • 68
    Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990; 344: 2457.
  • 69
    Brass DM, Hoyle GW, Poovey HG, Liu JY, Brody AR. Reduced tumor necrosis factor-alpha and transforming growth factor-beta1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure. Am J Pathol 1999; 154: 85362.
  • 70
    Rossmanith W, Schulte-Hermann R. Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech 2001; 15: 4306.
  • 71
    Zhai R, Jetten M, Franssen H, Schins RPF, Borm PJA. Tumor necrosis factor-gene polymorphism in ex-coal workers with and without coal workers' pneumoconiosis. Am J Ind Med 1998; 34: 31824.
  • 72
    Borm PJA, Schins RPF. Genotype and phenotype in susceptibility to coal workers' pneumoconiosis (CWP). The use of cytokines in perspective. Eur Respir J 2001; 18(Suppl 32): 127S33S.
  • 73
    Mahlke W. Morphologische und morphometrische Untersuchungen an der Rattenlunge nach Lanzeitexposition mit 5 verschiedenen nicht toxischen und schwerlösliche Stäuben. Dissertation. Göttingen: University of Göttingen, 2003.
  • 74
    Greim H, Borm P, Schins R, Donaldson K, Driscoll K, Hartwig A, Kuempel E, Oberdorster G, Speit G. Toxicity of fibers and particles. Report of the workshop held in Munich, Germany, 26–27 October 2000. Inhal Toxicol 2001; 13: 73754.
  • 75
    Fryzek JP, Chadda B, Marano D, White K, Schweitzer S, McLaughlin, Blot WJ. A cohort mortality study among titanium dioxide manufacturing workers in the United States. J Occup Environ Med 2003; 45: 4009.
  • 76
    Knaapen AM, Albrecht C, Becker A, Höhr D, Winzer A, Haenen GR, Borm PJA, Schins RPF. DNA damage in lung epithelial cells isolated from rats exposed to quartz: role of surface reactivity and neutrophilic inflammation. Carcinogenesis 2002; 23: 111120.
  • 77
    Driscoll KE, Deyo LC, Carter JM, Howard BW, Hassenbein DG, Bertram TA. Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. Carcinogenesis 1997; 18: 42330.
  • 78
    Johnston CJ, Driscoll KE, Finkelstein JN, Baggs R, O'Reilly MA, Carter J, Gelein R, Oberdorster G. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol Sci 2000; 56: 40513.
  • 79
    Gavett SH, Carakostas MC, Belcher LA, Warheit DA. Effect of circulating neutrophil depletion on lung injury induced by inhaled silica particles. J Leukoc Biol 1992; 51: 45561.
  • 80
    Auten RL, Whorton MH, Mason SN. Blocking neutrophil influx reduced DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Moll Biol 2002; 26: 3917.
  • 81
    Bermudez E, Mangnum JB, Asgharian B, Wong BA, Reverdy EE, Hexp PM, Warheit DB, Everitt JI. Long-term pulmonary response of three laboratory rodents to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 2002; 70: 8697.
  • 82
    Driscoll KE, Carter JM, Borm PJA. Antioxidant defense mechanisms and the toxicity of fibrous and nonfibrous particulate matter. Inhal Toxicol 2000; 14: 10118.
  • 83
    Janssen YMW, Marsh JP, Absher MP, Hemenway D, Vacek PM, Leslie KO, Borm PJA, Mossman BT. Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. J Biol Chem 1992; 267: 1062530.
  • 84
    Melby PC, Chandrasekar B, Zhao W, Coe JE. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 2001; 166: 191220.
  • 85
    Green FHY. Pulmonary responses to inhaled poorly soluble particulate in the human. Inhal Toxicol 2002; 12: 5995.
  • 86
    Sandhu H, Dehnen W, Roller M, Abel J, Unfried K. mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats. Carcinogenesis 2000; 21: 10239.
  • 87
    Schins RPF, Borm PJA. Mechanisms and mediators in coal dust toxicity: a review. Ann Occup Hyg 1999; 43: 733.
  • 88
    Vanhee D, Gosset P, Boitelle A, Wallaert B, Tonnel AB. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J 1995; 8: 83442.
  • 89
    Schins RPF, Schilderman PAEL, Borm PJA. Oxidative DNA damage in peripheral blood lymphocytes of coal workers. Int Arch Occup Environ Health 1995; 67: 1537.
  • 90
    IARC. Monographs on the evaluation of carcinogenic risks to humans: silica, some silicates, coal dusts and para-aramid fibrils. vol. 68. Lyon: IARC, 1997.
  • 91
    Kuempel ED, O'Flaherty EJ, Stayner LT, Smith RJ, Green FH, Vallyathan V. A biomathematical model of particle clearance and retention in the lungs of coal miners. Regul Toxicol Pharmacol 2001; 34: 6987.
  • 92
    Tran CL, Buchanan DE. Development of a biomathematical lung model to describe the exposure–dose response relationship for inhaled dust among UK coal miners. IOM Research Report TM/00/02. Institute for Occupational Medicine Edinburgh: 2000.
  • 93
    Ghio AJ, Devlin RB. Inflammatory lung injury after bronchial instillation of air pollution particles. Am J Respir Crit Care Med 2001; 164: 7048.
  • 94
    Granum B, Lovik M. The effects of particles on allergic immune response. Toxicol Sci 2002; 65: 717.
  • 95
    Kuempel ED, Attfield MD, Vallyathan V, Lapp NL, Hale JM, Smith RJ, Castranova V. Pulmonary inflammation and crystalline silica in respirable coal mine dust: dose-response. J Biosci 2003; 28: 619.
  • 96
    Engelen JJM, Borm PJA, Sprundel van M, Leenaerts L. Blood antioxidant parameters at different stages of pneumoconiosis in coal workers. Environ Health Perspect 1990; 84: 16572.
  • 97
    Evelo CTA, Bos RP, Borm PJA. Decreased glutathione content and glutathione S-transferase activity in red blood cells of coal miners with early stages of pneumoconiosis. Br J Ind Med 1993; 50: 6336.
  • 98
    Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary diseases—state of the art. Am J Respir Crit Care Med 1997; 156: 34157.
  • 99
    Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke–induced airway disease. Am J Physiol 1999; 277: L106788.
  • 100
    Behr J, Degenkolb B, Beinert T, Krombach F, Vogelmeier C. Pulmonary glutathione levels in acute episodes of farmer's lung. Am J Respir Crit Care Med 2000; 161: 196871.
  • 101
    Schins RPF, DerHaag TJM, de Jong J, Bast A, Borm PJA. Serum total radical trapping antioxidant parameter (TRAP) in coal workers. Clin Chem 1994; 40: 14702.
  • 102
    Schins RPF, Keman S, Borm PJA. Blood antioxidant status in coal dust induced respiratory disorders: a longitudinal evaluation of multiple biomarkers. Biomarkers 1997; 2: 4550.
  • 103
    California EPA. Safe drinking water and Toxic Enforcement Act of 1986. Proposition 65. Notice to interested parties. February 21, 2003.
  • 104
    Fubini B. Surface reactivity in the pathogenic response to particulates. Environ Health Perspect 1997; 105(Suppl 5): 101320.